Donaubauer AJ, Tomic O, Mogge L, Müller SK, Futsaether CM, Liland KH, Huynh BN, von der Grün J, Balermpas P, Fleischmann M, Hautmann MG, Steger F, Bohr C, Hehr T, Stromberger C, Budach V, Schymalla M, Engenhart-Cabillic R, Kocik L, Geinitz H, Nestle U, Klautke G, Scherl C, Schubert P, Corradini S, Fietkau R, Gaipl US, Frey B, Haderlein M (2026)
Exploratory immunomonitoring during radiochemotherapy in HNSCC and machine-learning reveal immune parameters associated with disease-free survival
NPJ Precis Oncol, 10 (1)
DOI 10.1038/s41698-026-01658-w, PubMed 42675144

Heggebø LC, Hellebust TP, Henry T, Fjæra LF, Ottestad A, Rylander H, Hervani M, Evensen ME, Gustafsson M, Blakstad H, Sprauten M, Magelssen H, Moorthy J, Andersson KM, Dahlgren CV, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Bergström P, Agrup M, Kinhult S, Alkner S, Dahl L, Kristensen I, Gubanski M, Zupancic M, Strandeus M, Raunert I et al. (2026)
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries
Clin Transl Radiat Oncol, 60, 101220
DOI 10.1016/j.ctro.2026.101220, PubMed 42383068

Høgsbjerg KW, Thomsen MS, Boye K, Jensen I, Bekke SN, Lorenzen EL, Nissen HD, Saini A, Dybvik KI, Wieslander E, Tømmerås V, Mikalsen SG, Isacson U, Grahn C, Perander K, Uhláriková M, Nygaard B, Holmeset IM, Far Manríquez RE, Buhaug KP, Jensen MR, Overgaard J, Offersen BV, DBCG RT Committee (2026)
Radiotherapy quality assurance in the Danish breast cancer Group RT Natural trial
Clin Transl Radiat Oncol, 59, 101190
DOI 10.1016/j.ctro.2026.101190, PubMed 42291796